# Study Comparing the Safety and Efficacy of BOL-303259-X to Latanoprost in Subjects With Glaucoma or Ocular Hypertension

> **NCT01223378** · PHASE2 · COMPLETED · sponsor: **Bausch & Lomb Incorporated** · enrollment: 413 (actual)

## Conditions studied

- Intraocular Pressure

## Interventions

- **DRUG:** BOL-303259-X
- **DRUG:** Latanoprost

## Key facts

- **NCT ID:** NCT01223378
- **Lead sponsor:** Bausch & Lomb Incorporated
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-12-13
- **Primary completion:** 2011-12-20
- **Final completion:** 2012-06-22
- **Target enrollment:** 413 (ACTUAL)
- **Last updated:** 2018-07-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01223378

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01223378, "Study Comparing the Safety and Efficacy of BOL-303259-X to Latanoprost in Subjects With Glaucoma or Ocular Hypertension". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01223378. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*